PMC:7784830 / 22687-22856 JSONTXT

{"project":"LitCovid-sentences","denotations":[{"id":"T176","span":{"begin":0,"end":84},"obj":"Sentence"},{"id":"T177","span":{"begin":85,"end":169},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Vaxart Inc Oral recombinant vaccine in tablet formulation using its VAAST platform. It has protected its vaccine tablet formulation by US patent applications [107–109]"}